Cellebrite is a Israeli digital forensics company, they have something interesting in their investor presentation even though their products are not quite competing in the same space, but it's worth a read.
it seems like Nuix is valued at lower end amongst its competitor. Note this was presented back in March where Nuix is still at 1.5B-2B AUD, all Nuix's direct or indirect competitors are valued at much higher multiples(Relativity as well), so if the management from Nuix can prove everything is on track or back to growth trajectory, SP will go up significantly.
all in my own view and good luck
Nuix valuation from their competitor Cellebrite
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.93 |
Change
-0.030(1.01%) |
Mkt cap ! $956.0M | |||
| Open | High | Low | Value | Volume |
| $2.97 | $2.98 | $2.93 | $132.6K | 44.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1450 | $2.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.94 | 5305 | 14 |
View Market Depth
| Last trade - 11.08am 20/06/2024 (20 minute delay) ? |
| NXL (ASX) Chart |